CMPS
Compass Pathways Plc Health Care Pharmaceutical Preparations Russell 3000
$11.57Close
$1.1BMarket cap
$4.94 – $15.1952-week range
Nov 3, 2026Next report · before the open
Highlights
Strengths
- Leading the market RS 89 · stronger than 89% of stocks over 12 months
Cautions
- Trend not confirmed 6 of 8 conditions · under the 150/200-day, under the 50-day
- Results soon Nov 3, 2026, in 2 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
24%
1wk
up 3.5%
price change
1mo
down 7.0%
price change
12-month return
up 84%
market up 11% ·
its own up 72%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
down 18.3%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
—
return on equity
Free cash margin
—
-$157.2M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
Repair signals
- Long-term debt down 43% ($0.0B → $0.0B)
Trade setup
ATR%
5.6%
$0.65 a day · 2×ATR $10.26
RS
89 / 99
vs the universe
Trend
6 / 8
under the 150/200-day, under the 50-day
Relative volume
0.8×
vs 50-day average
Up/down volume
0.73
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 6 of 8
- Price above the 150 and 200-day averages: fails
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Liabilities exceed assets Shareholders' equity is negative at -$52.8M as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 40.2% over the year, from 69m to 96m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026+15% vs market2 sessions after results
Financials
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Operating income | -$51.4M | -$83.2M | -$110.4M | -$136.9M | -$178.2M | -$179.0M |
| Net income | -$60.3M | -$71.7M | -$91.5M | -$118.5M | -$155.1M | -$269.8M |
| Earnings per share | -$3.55 | -$1.79 | -$2.16 | -$2.32 | -$2.30 | -$2.89 |
| Free cash flow | -$41.5M | -$68.1M | -$106.0M | -$97.4M | -$119.2M | -$157.2M |
| Cash | $190.3M | $273.2M | $143.2M | $220.2M | $165.1M | $149.6M |
| Long-term debt | — | — | $0 | $28.8M | $24.7M | $14.1M |
| Shareholders' equity | $196.6M | $284.4M | $181.3M | $225.7M | $154.7M | -$52.8M |
| Shares outstanding | 35.93m | — | — | 61.94m | 68.55m | 96.09m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 13, 2026 | Quarterly ↗ | Mar 31, 2026 | 43d |
| Mar 24, 2026 | Annual ↗ | Dec 31, 2025 | 83d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Results ↗ |
| Jul 7, 2026 | Regulation FD · Other events ↗ |
| May 28, 2026 | Shareholder vote ↗ |
| May 13, 2026 | Results ↗ |
| Mar 24, 2026 | Results ↗ |
| Feb 19, 2026 | Material agreement · Regulation FD ↗ |
| Feb 17, 2026 | Regulation FD · Other events ↗ |
| Jan 7, 2026 | Material agreement · New obligation ↗ |
| Nov 4, 2025 | Results ↗ |
| Oct 29, 2025 | Director or officer change ↗ |
| Jul 31, 2025 | Results ↗ |
| Jul 29, 2025 | Director or officer change ↗ |